- 18 new behavioral health study findings to know
- How 5 systems are embedding behavioral health into clinical care
- ‘Who watches the watchmen?’ CMS tightens oversight of accrediting bodies — 8 things to know
- 8 hospital projects worth $1B+ in 2026
- UnitedHealth, FTC near insulin rebates settlement
- The hidden disparity built into healthcare interoperability
- Christus consolidates inpatient services at Texas hospital
- Health AI regulation gaps span scribes, prior authorization: 5 notes
- Is cardiac catheterization the new cataract surgery?
- CMS floats permanent status for Medicare drug price negotiations: 5 things to know
- 13 cybersecurity updates for ASC leaders to know
- The safety issue hiding in ASC staffing
- Elevance sues former chief execution officer over noncompete agreement
- 15% of pregnant women report current alcohol use: CDC
- 15% of pregnant women report current alcohol use: CDC
- California healthcare district board member resigns to apply for CEO role
- Vermont regulators greenlight new ASC
- What surgeons don’t understand about anesthesia
- National Real Estate Advisors acquires Montana medical campus with ASC, MOB
- 5 ASC, ambulatory leaders from the biggest health systems
- Ohio dentist to retire after 34 years, close practice
- Good news, bad news for DSOs
- California Health Worker Union, Hospital Association Tout Dueling Ballot Initiatives
- Nearly 13,000 dental professionals needed to fill shortage areas: HRSA
- The states with the widest anesthesiologist salary spreads
- Optum Rx, FTC posed for settlement in insulin pricing case
- 7 new behavioral health projects representing nearly $1B in investment
- How the fastest-growing DSO is expanding its network
- Program closures, practice openings & more: 5 oral surgery updates 30 days
- CMS proposes permanent framework for Medicare drug price negotiations
- Dental hygienist pay up 21% since 2021
- ‘Making a bad situation worse’: 15% of psych beds lost in 4 California counties after staffing rule
- How dentist pay has evolved over the last 5 years
- Nearly 30% of Massachusetts residents filled behavioral health prescriptions
- Rhode Island Senate advances bill creating licensure pathway for foreign-trained dentists, hygienists
- The 10 states where physician assistant pay jumped the most
- Anesthesia stipends by the numbers
- SAMHSA unveils $40M behavioral health grant funding: 5 things to know
- Best, worst states for child well-being
- 5 dental school updates to know
- 7 DSOs making headlines
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Mercer survey: Employers eye cost-shifting strategies as health benefit spend rises
- Nvidia, Abridge collaborate to develop healthcare-specific AI model
- Industry Voices—Why health systems need physicians engaged in IT leadership
- FDA hearing on Amgen's Tavneos will include findings from an independent review
- In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Sepsis, Lung Infection Patients See No Benefit From Remote Monitoring
- Overlooked Social Connections Can Prevent Suicide
- Final Rules for Medicaid Work Requirements Are Out. Here’s What You Need To Know.
- 1 in 4 Covered California Enrollees Could Get State Aid Under Newsom Proposal
- Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast
- Fierce Pharma Asia—Astellas CEO’s 5-year plan; Takeda’s psoriasis win; RA’s China bridge program
- Why this behavioral health provider just bought a pharmacy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- North Carolina awards $10M to expand rural behavioral healthcare access
- Healthcare costs poised to jump 9% in 2027 as health plans blame AI adoption, drug prices
- Provider groups file lawsuit against HHS over anti-trans Ryan White funding rules
- Genentech executes another round of layoffs, with 3 VPs axed
- Humana to sell off minority stake in end-of-life care provider Gentiva
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Novo reports data breach, tells clinical trial patients to 'remain vigilant'
- ‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff
- OIG: Frequent MA prior authorization denials for long-term care hospitals, inpatient rehab
- From Medicaid work requirement exemptions to AI safeguards in coverage: New AMA policies from annual meeting
- Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure
- J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win
- Virtual care tech companies launch 'out-of-the-box' RPM tool for pharmacies
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- Living With Cats Not Linked To Worse Asthma in Children
- Few Stroke, Brain Injury Survivors Get Top-Quality Hospital Rehab
- Popular Joint Pain Supplement, Glucosamine, Might Increase Alzheimer's Risk, Study Says
- Anguished Parents. Doctors In Tears. Utah's Long Measles Outbreak Takes A Toll.
- Madrigal takes giant inflatable liver on US tour in disease awareness push
- Listen to the Latest ‘KFF Health News Minute’
- Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
- Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign
- Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown
- Hospital associations push CMS for higher 2027 pay bump, softer ramp-up for mandatory model
- AHIP 2026: Why Ascendiun CEO Paul Markovich is bullish on building out a digital health record for patients
- FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen
- Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
- Weekly Rundown: Karias Health launches AI companion; Mount Sinai, Wisp partner to expand PrEP access in NY
- Sugary Beverages May Raise Your Risk of Liver Cancer
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Ardent Health's surprise CEO change reflected need for margin focus amid headwinds, CFO says
- FDA Approves First New Sunscreen Ingredient, Bemotrizinol, in Two Decades
- Trustees expect Medicare Trust Fund's reserves to run out in 2033
- Vega Health licenses AI models from Parkland Center for Clinical Innovation to predict patient risks
- Eli Lilly yells ‘action’ on authentic patient portrayals at Tribeca Festival
- Teen Recovering From Concussion? A 'Sweet Spot' For Screen Time Could Speed Up Their Recovery
- Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters
- AMA issues policy urging exemptions in upcoming Medicaid work requirements
- Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
- Teva to lay off 250 at API unit as search for new owner drags on: report
- Women Hit Harder By Sleep Apnea Than Men, Study Finds
- Retro Video Game Aids Stroke Recovery, Improves Arm Function
- Experimental, Once-Daily GLP-1 Pill, Elecoglipron, May Offer New Option for Weight Loss, Diabetes
- Anguished Parents. Doctors in Tears. Utah’s Long Measles Outbreak Takes a Toll.
- Looming Medicaid Cuts Supercharge California’s Latest Labor-Industry Fight
- Genentech and Novartis dish up food allergy microdrama series
- ‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
- Merck, Gilead score in effort to develop the first weekly HIV pill
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AI medical advice changes care decisions of most users: survey
- FDA Expands Sunscreen Options for the First Time in 20 Years
- Children's Well-Being Plummets Across 29 States, Report Finds
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Upcoming Billing Change Could Make Pregnancy Pricier
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
- Commission Statement on the Passing of Former General Counsel David Becker
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
Michigan healthcare freedom community forum
Robert F. Kennedy, Jr. was excoriated by Democratic Senators during nomination hearings before the Senate Finance & the Health, Education, Labor and Pensions Committees. Curiously, RFK, Jr. happens to still be a Democrat. One possible reason for his abuse at the hand of his fellow Democrats would be the Democratic Senators consider him an apostate for participating in President Trump's campaign and victory. The other possibility is the Democratic Senators are owned body and soul by Big Pharma and other anti MAHA (Make America Healthy Again) interests.
The Democratic propagandists in the main stream media are not covering this story because Champagne Socialist Bernie Sanders and Heap Big Faker Elizabeth "Pocahontas" Warren seem to be the most thoroughly compromised, but the story is getting some traction in alternative media:
RFK Jr. Exposes Big Pharma-Backed Senators During His Confirmation Hearing
By RVM News Staff - January 31, 2025Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services (HHS) sparked contentious debate in the Senate this week, bringing renewed attention to the influence of pharmaceutical and health industry donations on lawmakers.
During a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on Thursday, Kennedy defended his record against critics while senators questioning him found their own financial ties to the healthcare industry under scrutiny.
Senate HELP Committee Chair Bill Cassidy (R-LA) questioned Kennedy’s past statements on vaccines, including those related to measles and Hepatitis B.
While expressing concerns over Kennedy’s views, Cassidy acknowledged the nominee’s broad popular support.
“My responsibility is to learn, to try to understand if you can be trusted to support the best public health,” Cassidy said.
“A worthy movement called MAHA [Make America Healthy Again] to improve the health of Americans, or to undermine it, always asking for more evidence and never accepting the evidence that is there. That’s my dilemma, man. So you may be hearing from me over the weekend.”
Meanwhile, Kennedy and his supporters have pointed to the role of pharmaceutical industry donations in the confirmation process.
“Our kids are getting sicker and sicker. All of the people here who are defending this current system, and defending these pharmaceutical profits, are taking huge amounts of money from the pharmaceutical industry,” Kennedy said.
“This is not making our country healthier. It’s making our country sicker. We need to get rid of these conflicts.”
The role of industry donations in the confirmation process has drawn heightened attention, particularly regarding members of the Senate Finance Committee and the HELP Committee.
The watchdog group OpenSecrets has tracked contributions from pharmaceutical companies, health professionals, and related industries to committee members over the past five years.
Senate Finance Committee Ranking Member Ron Wyden (D-OR) has received significant contributions from the health sector between 2019 and 2024, including $749,316 from health professionals, $652,004 from insurers, $539,242 from health services and HMOs, and $502,063 from the pharmaceutical industry.
His top donors include Blue Cross/Blue Shield and Centene Corporation.
Cassidy, who expressed uncertainty over Kennedy’s confirmation, received $1,623,298 from health professionals and $996,737 from the pharmaceutical industry from 2019 to 2025, with Ochsner Health System as one of his top donors.
Even senators known for their criticism of the pharmaceutical industry have come under scrutiny.
Sen. Elizabeth Warren (D-MA) raised concerns that Kennedy’s lawsuits against pharmaceutical companies could financially damage vaccine manufacturers.
However, Warren has received $498,074 from health professionals, $126,056 from the pharmaceutical industry, and $109,065 from hospitals and nursing homes over the same period.
Sen. Bernie Sanders (I-VT), a longtime critic of corporate influence, has received $115,690 from the pharmaceutical industry and $159,233 from the food and beverage industry.
Sen. Bernie Sanders speaks at Erie High School in support of the Harris/Walz presidential campaign in Erie on Oct. 26, 2024.
During Kennedy’s testimony, Sanders was challenged on the $1,417,633 in contributions from pharmaceutical industry employees during his 2020 presidential campaign.“The problem of corruption is not just in the federal agencies. It’s in the Congress too,” Kennedy said.
“Almost all the members of this panel, including yourself, are accepting millions of dollars from the pharmaceutical industry and protecting their interests.”
Sanders defended his contributions, stating, “I ran for president like you. I got millions and millions of contributions. They did not come from the executives, not one nickel of PAC money from the pharmaceutical industry. They came from workers.”
Beyond campaign contributions, several senators overseeing Kennedy’s confirmation hold personal financial interests in industries that could be affected by his policies.
Wyden’s spouse owns stock valued between $50,000 and $100,000 in Restaurant Brands International Inc., which owns Burger King, Popeyes, and Firehouse Subs, as well as an investment worth between $1,001 and $15,000 in Pfizer.
Sen. Susan Collins (R-ME), a member of the HELP Committee, has financial ties to multiple industries regulated by HHS.
Her spouse owns stocks valued between $15,000 and $50,000 in companies such as EcoLab Inc., The Hershey Company, Johnson & Johnson, Merck & Co., and Thermo Fisher Scientific Inc.
Sen. Mark Warner (D-VA) has between $1 million and $5 million invested in Health Velocity Capital I, LP, a hedge fund focusing on healthcare technology, along with between $250,000 and $500,000 in Health Velocity II, LP, a venture capital fund.
While many senators on both sides of the aisle remain skeptical of Kennedy’s nomination, some have voiced strong support.
Sen. Marsha Blackburn (R-TN), one of the top recipients of pharmaceutical industry contributions in 2023-2024, has endorsed Kennedy’s nomination.
“It’s time to confirm RFK Jr. as HHS Secretary. He is ready to MAHA,” Blackburn said during the Senate Finance Committee hearing.
Kennedy’s confirmation remains uncertain as senators weigh his nomination against their own industry ties, with both his critics and supporters facing public scrutiny over their financial relationships with the healthcare sector.
In the 2019-20 Congressional funding cycle, Sanders received more money from people employed in the field classified by Open Secrets as "pharmaceuticals/health products" ($1.4 million) than any other member of Congress. He also received roughly $400,000 from people employed in "pharmaceutical manufacturing."
Elizabeth Warren raked in roughly $5 million from the health industry during her presidential bid in 2020.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















